Published in J Virol on December 01, 1975
Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus. J Virol (1976) 3.94
Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J Virol (1993) 3.53
Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol (1977) 3.32
Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. J Virol (2001) 3.22
Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J Virol (1977) 3.07
Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J Virol (1993) 2.42
Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother (1983) 2.09
Molecular genetics of herpes simplex virus. III. Fine mapping of a genetic locus determining resistance to phosphonoacetate by two methods of marker transfer. J Virol (1979) 1.97
Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate. Antimicrob Agents Chemother (1978) 1.84
Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene. J Virol (1987) 1.67
Characterization of the bovine herpesvirus 4 major immediate-early transcript. J Virol (1991) 1.60
Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication. Antimicrob Agents Chemother (1984) 1.58
Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice. Infect Immun (1977) 1.49
Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit. J Virol (1989) 1.45
Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed. J Virol (1991) 1.43
Characterization of an Epstein-Barr virus-induced DNA polymerase. J Virol (1979) 1.36
Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol (1997) 1.25
Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. Proc Natl Acad Sci U S A (1976) 1.22
Molecular biology and immunology of cytomegalovirus. Biochem J (1987) 1.19
Human cytomegalovirus induces the activity and expression of acetyl-coenzyme A carboxylase, a fatty acid biosynthetic enzyme whose inhibition attenuates viral replication. J Virol (2011) 1.15
Identification and characterization of a major early cytomegalovirus DNA-binding protein. J Virol (1986) 1.14
Inhibition of calmodulin-dependent kinase kinase blocks human cytomegalovirus-induced glycolytic activation and severely attenuates production of viral progeny. J Virol (2010) 1.01
Fusion of the termini of the murine cytomegalovirus genome after infection. J Virol (1984) 0.98
Preferential inhibition of herpes-group viruses by phosphonoacetic acid: effect on virus DNA synthesis and virus-induced DNA polymerase activity. Yale J Biol Med (1976) 0.97
Phosphonoacetic acid in the treatment of simian varicella. Antimicrob Agents Chemother (1978) 0.97
Interactions between human cytomegalovirus IE1-72 and cellular p107: functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity. J Virol (2003) 0.96
Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. PLoS Pathog (2011) 0.96
Isolation and characterization of phosphonoacetic acid-resistant mutants of human cytomegalovirus. J Virol (1987) 0.92
Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome. J Virol (1988) 0.91
Distinguishing cytomegalovirus, mycoplasma, and cellular DNA polymerases. J Virol (1976) 0.91
Phosphonoacetic acid-resistant mutants of herpes simplex virus: effect of phosphonoacetic acid on virus replication and in vitro deoxyribonucleic acid synthesis in isolated nuclei. Antimicrob Agents Chemother (1977) 0.90
Phosphonoacetic Acid inhibition of frog virus 3 replication. J Virol (1980) 0.88
Activity of the cytomegalovirus genome in the presence of PPi analogs. J Virol (1985) 0.87
Gammaherpesvirus 68 infection of endothelial cells requires both host autophagy genes and viral oncogenes for optimal survival and persistence. J Virol (2011) 0.86
Virus replication and localization of varicella-zoster virus antigens in human embryonic fibroblast cells infected with cell-free virus. Infect Immun (1980) 0.82
Prevention of infections with cytomegalovirus. Yale J Biol Med (1976) 0.82
Structure-activity studies on phosphonoacetate. Antimicrob Agents Chemother (1985) 0.80
Cytofluorometry of lymphocytes infected with Epstein-Barr virus: effect of phosphonoacetic acid on nucleic acid. J Virol (1978) 0.80
Host-viral effects of chromatin assembly factor 1 interaction with HCMV IE2. Cell Res (2011) 0.79
Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals. Mol Cell Proteomics (2017) 0.78
The eIF4AIII RNA helicase is a critical determinant of human cytomegalovirus replication. Virology (2016) 0.77
Deoxyribonucleic acid polymerase of wild-type and phosphonoacetic acid-resistant mutant of herpes simplex virus. Antimicrob Agents Chemother (1978) 0.75
Estrogen-related receptor α is required for efficient human cytomegalovirus replication. Proc Natl Acad Sci U S A (2014) 0.75
A quantitative assay for DNA-RNA hybrids with DNA immobilized on a membrane. J Mol Biol (1965) 32.99
Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med (1956) 7.35
Inhibition of herpes simplex virus replication by phosphonoacetic acid. Antimicrob Agents Chemother (1974) 4.50
Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43
Inhibition of DNA polymerase from herpes simplex virus-infected wi-38 cells by phosphonoacetic Acid. J Virol (1975) 4.42
Human cytomegalovirus. III. Virus-induced DNA polymerase. J Virol (1975) 4.06
Suppression of herpes simplex virus infection by phosphonoacetic acid. Appl Microbiol (1973) 4.04
Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication. J Virol (1973) 3.48
Pharmacology of viruses. Annu Rev Pharmacol (1970) 2.00
Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains. Antimicrob Agents Chemother (1972) 1.79
Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients. Antimicrob Agents Chemother (1973) 1.20
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Structural polypeptides of simian virus 40. J Virol (1971) 4.83
Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43
Human cytomegalovirus. III. Virus-induced DNA polymerase. J Virol (1975) 4.06
Analysis of simian virus 40 DNA with the restriction enzyme of Haemophilus aegyptius, endonuclease Z. J Virol (1973) 3.98
Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 3.82
Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol (1977) 3.17
Human cytomegalovirus genome: partial denaturation map and organization of genome sequences. J Virol (1977) 2.63
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Detection of human cytomegalovirus and analysis of strain variation. Yale J Biol Med (1976) 2.53
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol (1997) 2.24
Structure and function of the polypeptides in simian virus 40. I. Existence of subviral deoxynucleoprotein complexes. J Virol (1972) 2.16
Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol (1995) 2.16
Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob Agents Chemother (1983) 2.09
Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol (2001) 2.07
Ab initio construction of protein tertiary structures using a hierarchical approach. J Mol Biol (2000) 2.05
E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol Cell Biol (1992) 2.01
Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3). Mol Cell Biol (1993) 2.00
Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol (1974) 1.99
Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer (1980) 1.90
Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol (1976) 1.87
Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A (1993) 1.84
Factors affecting the ability of energy functions to discriminate correct from incorrect folds. J Mol Biol (1997) 1.84
Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J Immunol (1999) 1.79
Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J Virol (1997) 1.78
Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J Virol (1993) 1.73
Cytotoxicity of sesquiterpene lactones. Cancer Res (1971) 1.71
Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology (1992) 1.64
The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J Virol (1996) 1.63
Nucleotide sequence of a human cytomegalovirus DNA fragment encoding a 67-kilodalton phosphorylated viral protein. J Virol (1985) 1.62
Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet (1982) 1.59
Cytomegalovirus: genetic variation of viral genomes. Ann N Y Acad Sci (1980) 1.59
Mapping and expression of a human cytomegalovirus major viral protein. J Virol (1984) 1.55
Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin. J Virol (1975) 1.48
Autologous human B and T lymphoblastoid cell lines. Nature (1974) 1.48
Structure and function of the polypeptides in simian virus 40. II. Transcription of subviral deoxynucleoprotein complexes in vitro. J Virol (1972) 1.47
Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J Virol (1992) 1.46
Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med (1980) 1.46
The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J Virol (1996) 1.44
Epstein-Barr virus-associated thymidine kinase. J Virol (1978) 1.38
Analysis and mapping of a family of 3'-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J Virol (1995) 1.37
Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res (2000) 1.37
The role of MKK1/2 kinase activity in human cytomegalovirus infection. J Gen Virol (2001) 1.35
Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38. J Virol (2000) 1.33
Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. Biotechnol Appl Biochem (1988) 1.32
Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate. J Biol Chem (1988) 1.32
Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests. J Immunol (1974) 1.31
Cytomegalovirus D.N.A. and adenocarcinoma of the colon: Evidence for latent viral infection. Lancet (1978) 1.31
Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies. Int J Cancer (1981) 1.26
Are predicted structures good enough to preserve functional sites? Structure (1999) 1.26
Human cytomegalovirus-associated DNA polymerase and protein kinase activities. J Gen Virol (1981) 1.23
Cytomegalovirus infection stimulates expression of monocyte-associated mediator genes. J Immunol (1989) 1.22
Cytomegalovirus infection and viral-induced transformation of human endothelial cells. J Med Virol (1988) 1.21
Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res (1998) 1.21
Purification and characterization of varicella-zoster virus-induced DNA polymerase. J Virol (1978) 1.17
Effect of 9-(2-hydroxyethoxymethyl)guanine on viral-specific polypeptide synthesis in human cytomegalovirus-infected cells. Am J Med (1982) 1.17
The role of turns in the structure of an alpha-helical protein. Nature (1993) 1.17
Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem Pharmacol (1996) 1.16
Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro. J Gen Virol (1984) 1.15
Cytomegalovirus vaccine virus (Towne strain) does not induce latency. J Infect Dis (1985) 1.11
Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. Virology (1989) 1.11
A combined approach for ab initio construction of low resolution protein tertiary structures from sequence. Pac Symp Biocomput (1999) 1.11
Restriction endonuclease analysis of cytomegalovirus deoxyribonucleic acid as an epidemiologic tool. Pediatrics (1982) 1.10
Constructing side chains on near-native main chains for ab initio protein structure prediction. Protein Eng (2000) 1.09
Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. Ann Intern Med (1985) 1.06
Human cytomegalovirus induces expression of cellular topoisomerase II. J Virol (1990) 1.06
Cytomegalovirus: detection in human colonic and circulating mononuclear cells in association with gastrointestinal disease. Int J Cancer (1981) 1.02
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med (1979) 1.01
Persistence of CMV genome in lymphoid cells after congenital infection. Nature (1975) 1.01
High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J Infect Dis (1993) 0.99
Iodination of herpesvirus nucleic acids. J Virol (1975) 0.97
Preferential inhibition of herpes-group viruses by phosphonoacetic acid: effect on virus DNA synthesis and virus-induced DNA polymerase activity. Yale J Biol Med (1976) 0.97
Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences. J Gen Virol (1999) 0.97
Characterization of a structurally tricistronic gene of human cytomegalovirus composed of U(s)18, U(s)19, and U(s)20. J Virol (1993) 0.97
Synthesis of sex steroids by cellular components of chicken follicles. Biol Reprod (1979) 0.97
Genetic analysis of a cytomegalovirus-like agent isolated from human brain. J Virol (1978) 0.96
Chromatin pattern consisting of repeating bipartite structures in WI-38 cells infected with human cytomegalovirus. J Virol (1978) 0.94
In vitro expression of the human cytomegalovirus DNA polymerase gene: effects of sequence alterations on enzyme activity. J Virol (1993) 0.93
Simultaneous congenital infection with Epstein-Barr virus and cytomegalovirus. N Engl J Med (1981) 0.93
Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. Scand J Infect Dis Suppl (1995) 0.92
Murine cytomegalovirus-induced congenital defects and fetal maldevelopment. J Infect Dis (1983) 0.92
Cervical cytomegalovirus infection in prostitutes and in women attending a sexually transmitted disease clinic. J Med Virol (1994) 0.92
Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome. J Virol (1988) 0.91
Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells. J Biol Chem (1999) 0.91
Cytomegalovirus excretion in pregnant and nonpregnant women. J Clin Microbiol (1993) 0.90
Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture. Endocrinology (1983) 0.90
Demonstration of developmental anomalies in mouse fetuses by transfer of murine cytomegalovirus DNA-injected eggs to surrogate mothers. J Infect Dis (1993) 0.89
Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H - imidazole on HCMV DNA replication and permissive infection. Antiviral Res (1999) 0.88
Cytomegalovirus infection and viral shedding in the genital tract of infertile couples. J Med Virol (1995) 0.88
Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts. Mol Biol Cell (1992) 0.87
Productive infection of human endometrial stromal cells by human cytomegalovirus. Virology (1994) 0.86
Antitumor agents. 207. Design, synthesis, and biological testing of 4beta-anilino-2-fluoro-4'-demethylpodophyllotoxin analogues as cytotoxic and antiviral agents. J Med Chem (2001) 0.86
The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells. Biochem Biophys Res Commun (1987) 0.86
Replication of cytomegalovirus DNA in human lymphoblastoid cells. IARC Sci Publ (1975) 0.85
Glioblastoma cell-specific expression of fibroblast growth factor receptor-1beta requires an intronic repressor of RNA splicing. Cancer Res (1999) 0.85
Human cytomegalovirus and herpes simplex type 2 virus in normal and adenocarcinomatous prostate glands. J Natl Cancer Inst (1983) 0.84